You are here

  • Home
  • Archive
  • Volume 28, Issue 1
  • Endometrial Cancers Harboring Mutated Fibroblast Growth Factor Receptor 2 Protein Are Successfully Treated With a New Small Tyrosine Kinase Inhibitor in an Orthotopic Mouse Model

Citation Tools

Article menu
Download PDFPDF
Uterine Cancer
Endometrial Cancers Harboring Mutated Fibroblast Growth Factor Receptor 2 Protein Are Successfully Treated With a New Small Tyrosine Kinase Inhibitor in an Orthotopic Mouse Model

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Taurin S, Yang C, Reyes M, et al
Endometrial Cancers Harboring Mutated Fibroblast Growth Factor Receptor 2 Protein Are Successfully Treated With a New Small Tyrosine Kinase Inhibitor in an Orthotopic Mouse Model
International Journal of Gynecologic Cancer 2018;28:152-160.